zurück	ARO 97-1, CHARTWEL
CHART	Continuous hyperfractionated accelerated radiotherapy. CHARTWEL = CHART weekend less
Ergebnis
Patienten	406 NSCLC
CHARTWEL	60Gy, ED 1,5Gy, 40 Fraktionen in 2,5 Wochen, 3x/Tag
Conventionel	66Gy, ED 2 Gy, 33 Fraktionen in 6,5 Wochen, 1x/Tag
Ergebnis	Parameter CHARTWEL Conventionel Statistik 2a-OS 31% 32% n.s. 3a-OS 22% 18% n.s. 5a-OS 11% 7% n.s.
	1.) Baumann M, et al.: Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 (2011):76-85

Impressum .....................................................................................Zuletzt geändert am 23.09.2012 8:10